Biologics Safety Testing Market : Technological advancements in the field of Vaccine Development

(EMAILWIRE.COM, February 05, 2021 ) The global biologics safety testing market is expected to reach USD 4.90 Billion by 2022 from USD 2.75 Billion in 2017, at a CAGR of 12.2% during forecast period. The major factors driving the growth of this market are the growth in pharmaceutical & biotechnology...